Full metadata record
DC FieldValueLanguage
dc.creatorCano, D. (David)-
dc.creatorLasarte, J.J. (Juan José)-
dc.creatorVivas, I. (Isabel)-
dc.date.accessioned2023-04-14T09:53:44Z-
dc.date.available2023-04-14T09:53:44Z-
dc.date.issued2022-
dc.identifier.citationCano-Rafart, D. (David); Lasarte-Sagastibelza, J. (Juan José); Vivas-Pérez, I. (Isabel). "Electroporación irreversible: presente y futuro en el tratamiento del carcinoma hepatocelular". Anales del Sistema Sanitario de Navarra. 45 (3), 2022, e1019es
dc.identifier.issn1137-6627-
dc.identifier.urihttps://hdl.handle.net/10171/65916-
dc.description.abstractCurrently, among the possible treatments for hepatocel-lular carcinoma there is group of minimally invasive abla-tion techniques with wide clinical acceptance due to their greater efficacy and safety in comparison to traditional therapies, low cost, and no need of being admitted to hospi-tal (outpatient treatment program). Irreversible electroporation is a non-thermal abla tion technique in which electrical fields are used to create nan-opores in the cell membrane that induce tumor cell death.Irreversible electroporation has shown promising results in numerous clinical trials; however, its control on long-term tumor growth and recurrence is inferior in comparison to that of radiofrequency. Combining irreversible electropora-tion with immunological agents may increase its efficacy in the treatment of focal lesions and metastases. In this work, we present an update on IRE including procedure, mecha-nism of action, application as a treatment for HCC, and the improvements that have been made in the past few years.-
dc.language.isoes-
dc.rightsinfo:eu-repo/semantics/openAccess-
dc.subjectCarcinoma hepatocelular-
dc.subjectElectroporación-
dc.subjectAgentes inmunológicos-
dc.subjectHepatocellular carcinoma-
dc.subjectElectroporation-
dc.subjectImmunologic agents-
dc.titleElectroporación irreversible: presente y futuro en el tratamiento del carcinoma hepatocelular-
dc.title.alternativeIrreversible electroporation: present and future in the treatment of hepatocellular carcinoma-
dc.typeinfo:eu-repo/semantics/article-
dc.description.noteArtículo Open Access distribuido bajo Licencia Creative Commons Atribución-Compartirigual 4.0 Internacional-
dc.identifier.doi10.23938/ASSN.1019-
dadun.citation.number3-
dadun.citation.publicationNameAnales del Sistema Sanitario de Navarra-
dadun.citation.startingPagee1019-
dadun.citation.volume45-
dc.identifier.pmid36413004-

Files in This Item:
Thumbnail
File
pdf.pdf
Description
Size
228.26 kB
Format
Adobe PDF


Statistics and impact
0 citas en
0 citas en

Items in Dadun are protected by copyright, with all rights reserved, unless otherwise indicated.